Relatively newer agent latanoprost is now being used. Which of the following statements is true regarding this agent?: (A) It is PGF2α derivative used in glaucoma, (B) It is selective α1 blocker used in benign hypertrophy of prostate, (C) It is a 5α reductase inhibitor used to reduce the size of enlarged prostate gland, (D) It is a PGE2  analogue used intravaginally for cervical priming
Answer is A. None